[ORGANIZATION]
Regeneron Pharmaceuticals
Featured in 13 tracked stories · first seen
Situations
Lito Sousa dies at 59 after battle with CJD
17 clusters · 170 sources · last updated
Latest: Lito Sousa AI video sparks controversy among followers
Lito Sousa, a 59-year-old aviation specialist and creator of the YouTube channel ‘Aviões e Músicas’, has died following a battle with Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition. During
Regeneron Pharmaceuticals market performance and competition
2 clusters · 3 sources · last updated
Latest: Regeneron Pharmaceuticals stock faces pressure from ophthalmology competition
Regeneron Pharmaceuticals has experienced a period of significant financial activity characterized by strong revenue growth alongside stock price volatility. Earlier reports indicated a 17% year-over-year revenue increa
Veeva Systems life sciences technology expansion
2 clusters · 5 sources · last updated
Latest: Healthcare sector analysis: AbbVie, Novo Nordisk, and BridgeBio Pharma
Veeva Systems has expanded its life sciences technology suite through new pharmaceutical partnerships and product launches. Companies including Biogen and Regeneron Pharmaceuticals have selected Veeva Vault CRM to modern
Lito Sousa medical treatment for Creutzfeldt-Jakob disease
2 clusters · 48 sources · last updated
Latest: Anvisa authorizes experimental drug import for pilot Lito Sousa
Lito Sousa, a prominent Brazilian aviation influencer, is battling Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition. Despite the aggressive nature of the disease, Sousa has reportedly maintai
Also covered in
-
Sanofi and Regeneron expand immunology drug alliance
[BUSINESS] · 3 sources ·
-
Kodiak Sciences shares surge on successful Phase III eye treatment trials
[BUSINESS] · 10 sources ·
-
Pharmaceutical companies face clinical trial setbacks
[BUSINESS] · 5 sources ·